- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Scott Page: Diversity in Healthcare Improves Patient Outcomes
Having healthcare professionals with different sets of experiences or different training can help create better solutions and improve patient outcomes, explained Scott Page, PhD, the Leonid Hurwicz Collegiate Professor of Complex Systems, Political Science, and Economics at the University of Michigan.
Having healthcare professionals with different sets of experiences or different training can help create better solutions and improve patient outcomes, explained Scott Page, PhD, the Leonid Hurwicz Collegiate Professor of Complex Systems, Political Science, and Economics at the University of Michigan.
Transcript
How can diversity be levered in healthcare to improve patient outcomes?
If the question is how does diversity give better health outcomes, I think you have to make a distinction between experiential diversity, training diversity, identify diversity, there’s lots of different types of diversity. What happens is when people have had a different set of experiences or filtered the world differently or have been trained differently and then a patient comes in and they’re resenting in a particular way that’s complex, then diversity turns out being really useful in terms of coming up with better solutions.
For example, the Vermont Oxford Network, which is a group of people who work in neonatal medicine. They get together and share ideas like what did we learn here, wat did we learn there. So, I think this is an interesting combination of being trained in different ways, having different patient experiences, and having different personal experiences where you maybe look at the world through different lenses that allows you to sort of see a particular presentation in greater granularity, different dimensionality, which I think leads to better outcomes.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
